ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

Possible Government Shutdown Looms Over Biomedical Research Funding Once More

September 23, 2011

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985